Latest / Decera Clinical Education Oncology Podcast
Bladder Cancer Breakthroughs: New NMIBC Therapies and EV + Pembrolizumab Updates From ASCO GU 2026
In this episode, Sam S. Chang, MD, MBA, and Matthew D. Galsky, MD, discuss the rapidly evolving treatment landscape in bladder cancer, highlighting new therapeutic options, emerging clinical trial data, including the latest results presented at ASCO GU 2026, and the growing role of biomarkers and multidisciplinary care, including:
New treatment options for BCG-unresponsive non–muscle-invasive bladder cancer
Intravesical therapies such as nadofaragene and N-803
The role of ctDNA in measurable residual disease detection
Presenters:
Sam S. Chang, MD, MBA
Patricia and Rodes Hart Chair of Urologic…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.